Petkau, J. M., & Eksteen, B. (2016). Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab. Biologics.
Citación estilo ChicagoPetkau, Jill MV, and Bertus Eksteen. "Selective Biologics for Ulcerative Colitis and Crohn’s Disease – Clinical Utility of Vedolizumab." Biologics 2016.
Cita MLAPetkau, Jill MV, and Bertus Eksteen. "Selective Biologics for Ulcerative Colitis and Crohn’s Disease – Clinical Utility of Vedolizumab." Biologics 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.